L
Lorenzo G. Mantovani
Researcher at University of Milan
Publications - 361
Citations - 38356
Lorenzo G. Mantovani is an academic researcher from University of Milan. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 51, co-authored 324 publications receiving 26740 citations. Previous affiliations of Lorenzo G. Mantovani include University of Naples Federico II & University of Milano-Bicocca.
Papers
More filters
Journal ArticleDOI
Anticoagulation Treatment in Cancer-Associated Venous Thromboembolism: Assessment of Patient Preferences Using a Discrete Choice Experiment (COSIMO Study)
Nils Picker,Agnes Y.Y. Lee,Agnes Y.Y. Lee,Alexander T. Cohen,Anthony Maraveyas,Jan Beyer-Westendorf,Lorenzo G. Mantovani,Khaled Abdelgawwad,Samuel Fatoba,Inga-Marion Thate-Waschke,Miriam Bach,Thomas Wilke +11 more
TL;DR: This study showed that treatment-related decision making in cancer-associated VTE, assuming comparable effectiveness and safety of anticoagulant treatments, is predominantly driven by “route of administration,” with patients strongly preferring oral administration.
Journal ArticleDOI
Sleeve gastrectomy with tailored 360° fundoplication according to Rossetti in patients affected by obesity and gastroesophageal reflux: a prospective observational study
Stefano Olmi,Giovanni Cesana,Lucia Sara D'Angiolella,Marta Bonaldi,Matteo Uccelli,Lorenzo G. Mantovani +5 more
TL;DR: In this paper, a prospective, observational cohort study was conducted to evaluate the effectiveness of LSG + Rossetti antireflux fundoplication in patients affected by morbid obesity and GERD.
Journal ArticleDOI
Sacubitril/valsartan in heart failure with reduced ejection fraction: cost and effectiveness in the Italian context.
Lucia Sara D'Angiolella,Paolo Cortesi,Claudia Pitotti,Daniela Ritrovato,Lorenzo G. Mantovani,Michele Senni +5 more
TL;DR: A cost-effectiveness analysis of the use of sacubitril/valsartan in Italy is performed, which is one of the most populated European countries, and found it to have higher efficacy than enalapril in reducing CV mortality and hospitalizations.
Journal ArticleDOI
Cost-effectiveness of different diagnostic strategies to assess gastro-oesophageal reflux disease in patients with unexplained chronic persistent cough in Italy.
TL;DR: This study shows that the lowest cost is the strategy where proton pump inhibitors test is performed as first investigation, which may lead to cost savings in the management of patients with chronic persistent cough.